CSBR (STOCKS)
Champions Oncology, Inc.
$5.080000
+0.130000 (+2.63%)
Prev close: $4.950000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Robert Brainin
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $71.27M
- Employees
- 306
- P/E (TTM)
- -60.96
- P/B (TTM)
- 17.45
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q4)
|
$-0.05 | $-0.05 | +0.0010 | +1.96% |
|
Mar 2026 (Q3)
|
$-0.02 | $0.09 | -0.1118 | -121.79% |
|
Dec 2025 (Q2)
|
$0.02 | $0.01 | +0.0098 | +96.08% |
|
Sep 2025 (Q1)
|
$0.02 | $-0.01 | +0.0302 | +296.08% |
Financial Statements
| Revenues | $59.43M |
| Benefits Costs and Expenses | $60.35M |
| Cost Of Revenue | $30.90M |
| Costs And Expenses | $60.35M |
| Gross Profit | $28.53M |
| Operating Expenses | $29.67M |
| Depreciation and Amortization | $1.38M |
| Research and Development | $9.08M |
| Other Operating Expenses | $19.20M |
| Operating Income/Loss | -$1.14M |
| Income/Loss From Continuing Operations After Tax | -$1.18M |
| Income/Loss From Continuing Operations Before Tax | -$929.00K |
| Income Tax Expense/Benefit | $246.00K |
| Income Tax Expense/Benefit, Current | $246.00K |
| Income Tax Expense/Benefit, Deferred | $0.00 |
| Net Income/Loss | -$1.18M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$1.18M |
| Net Income/Loss Available To Common Stockholders, Basic | -$1.18M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.08 |
| Diluted Earnings Per Share | -$0.08 |
| Basic Average Shares | 13,832,385 |
| Diluted Average Shares | 13,832,385 |
| Assets | $26.99M |
| Current Assets | $19.22M |
| Noncurrent Assets | $7.77M |
| Liabilities | $22.92M |
| Current Liabilities | $19.92M |
| Accounts Payable | $6.90M |
| Other Current Liabilities | $13.02M |
| Noncurrent Liabilities | $3.00M |
| Equity | $4.07M |
| Equity Attributable To Noncontrolling Interest | $129.00K |
| Equity Attributable To Parent | $3.94M |
| Liabilities And Equity | $26.99M |
| Net Cash Flow From Operating Activities | -$4.47M |
| Net Cash Flow From Operating Activities, Continuing | -$4.47M |
| Net Cash Flow From Investing Activities | -$540.00K |
| Net Cash Flow From Investing Activities, Continuing | -$540.00K |
| Net Cash Flow From Financing Activities | $99.00K |
| Net Cash Flow From Financing Activities, Continuing | $99.00K |
| Net Cash Flow | -$4.91M |
| Net Cash Flow, Continuing | -$4.91M |
| Comprehensive Income/Loss | -$1.18M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$1.18M |
| Other Comprehensive Income/Loss | $0.00 |